The global embryo incubator market is projected to grow from USD 90.2 million in 2025 to USD 146.9 million by 2035, with a compound annual growth rate (CAGR) of 5.0%. The UK shows promising growth in this sector, driven by favourable healthcare policies, increased awareness, and oversight from the Human Fertilisation and Embryology Authority (HFEA). Embryo incubators, vital for in-vitro fertilisation (IVF) and other fertility treatments, are experiencing increased demand due to rising infertility rates. The UK market is anticipated to grow at a CAGR of 5.0%, fostered by continuous investments in reproductive research and public acceptance of fertility solutions.